"L'Institut Sainte-Catherine est un établissement de santé privé d’intérêt collectif en Avignon spécialisé dans le dépistage et le traitement des cancers. Il est doté de 88 lits d’hospitalisation, 38 places d’hôpital de jour."

During the past decade, Institut Sainte Catherine;Recherche Clinique conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Sainte Catherine;Recherche Clinique" #1 collaborator was "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Institut Sainte Catherine;Recherche Clinique" are "Bladder Cancer" (1 trials), "Breast Cancer" (1 trials), "Carcinoma, Transitional Cell" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Muscle-invasive Bladder Cancer" (1 trials). Many other conditions were trialed in "Institut Sainte Catherine;Recherche Clinique" in a lesser frequency.

Most popular intervention types in "Institut Sainte Catherine;Recherche Clinique" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials), "Docetaxel" (1 trials), "Giredestrant" (1 trials) and "Giredestrant-matched Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Sainte Catherine;Recherche Clinique" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Institut Sainte Catherine;Recherche Clinique". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Institut Sainte Catherine;Recherche Clinique, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Sainte Catherine;Recherche Clinique, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".